ADMINISTRATIONThe Core is administered jointly by Drs. J. Rivier, B. Olivera, M. Mclntosh and W. Fischer. Priorities will beassigned in consultation with the users as defined in the application. In general, a first come, first served policywill be used to assign priority.The Advisory Committee consists of all of the Project Leaders of this Program (including the CoreDirectors). The Advisory Committee meets on a scheduled basis once a year, and will meet on an ad hocbasis as needed, in order to address new developments in the operation of the Core as well as to resolveconflicts, or to set priorities other than those derived from records of first come, first served. The servicesprovided by this Core have been provided to the Program in a timely and responsive manner since itsinception.We request support for only one-fourth of the personnel and costs associated with the optimal functioningof this Core, because of our similar commitments to other NIH agencies. Accurate and completedocumentation of peptide synthesis and analyses will be kept, using computer storage methods wherepossible. Similarly, Core B will keep the bulk of the material synthesized under its aegis for accurateaccounting, proper storage and distribution (with the applicable Project Leader's authorization) to other NIHsponsored researchers after publication of the results derived from the use of these peptides.NOTES:This Core will operate in the laboratories of the P.I. (J. Rivier). Laboratory space has been recentlyrenovated and designated specifically to fulfill the needs of the CDC for the synthesis and storage ofselect agents. The Facility is now registered with the CDC (see attached Certificate of Registration) tocarry out the proposed research, including the synthesis of conotoxins, their purification, storage andthe ability to transfer them to researchers under the conditions specified in the Salk's registrationapplication.The Salk's registration application is available upon request.
Showing the most recent 10 out of 277 publications
